XML 22 R6.htm IDEA: XBRL DOCUMENT v3.26.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Underwritten Public Offering
Common Stock
Common Stock
Underwritten Public Offering
Additional Paid-in Capital
Additional Paid-in Capital
Underwritten Public Offering
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2024 $ 71,525   $ 2   $ 677,859   $ (602,305) $ (4,031)
Balance, shares at Dec. 31, 2024     204,943,306          
Stock-based compensation 9,769       9,769      
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs   $ 215,646   $ 1   $ 215,645    
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs, shares       57,777,777        
Issuance of common stock upon exercise of pre-funded warrants, shares     9,607,145          
Issuance of common stock, upon vesting and settlement of restricted stock units, net (51)       (51)      
Issuance of common stock, upon vesting and settlement of restricted stock units, net, shares     1,299,156          
Issuance of common stock upon exercise of stock options, net 197       197      
Issuance of common stock upon exercise of stock options, net ,shares     164,838          
Issuance of common stock under ESPP 159       159      
Issuance of common stock under ESPP, shares     123,151          
Gain (loss) on instrument specific credit risk 2,888             2,888
Net loss (81,144)           (81,144)  
Balance at Sep. 30, 2025 218,989   $ 3   903,578   (683,449) (1,143)
Balance, shares at Sep. 30, 2025     273,915,373          
Balance at Jun. 30, 2025 248,727   $ 3   900,139   (650,716) (699)
Balance, shares at Jun. 30, 2025     272,730,060          
Stock-based compensation 3,285       3,285      
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs   (6)   $ 0   (6)    
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs, shares       0        
Issuance of common stock, upon vesting and settlement of restricted stock units, net, shares     1,049,338          
Issuance of common stock upon exercise of stock options, net 76       76      
Issuance of common stock upon exercise of stock options, net ,shares     71,150          
Issuance of common stock under ESPP 84       84      
Issuance of common stock under ESPP, shares     64,825          
Gain (loss) on instrument specific credit risk (444)             (444)
Net loss (32,733)           (32,733)  
Balance at Sep. 30, 2025 218,989   $ 3   903,578   (683,449) (1,143)
Balance, shares at Sep. 30, 2025     273,915,373          
Balance at Dec. 31, 2025 $ 246,938   $ 3   958,427   (711,300) (192)
Balance, shares at Dec. 31, 2025 285,051,648   285,051,648          
Stock-based compensation $ 17,439       17,439      
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs   215,632       215,632    
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs, shares       37,500,001        
Issuance of common stock, upon vesting and settlement of restricted stock units, net, shares     2,004,332          
Issuance of common stock upon exercise of stock options, net 2,137       2,137      
Issuance of common stock upon exercise of stock options, net ,shares     1,176,913          
Issuance of common stock under ESPP 463       463      
Issuance of common stock under ESPP, shares     150,986          
Gain (loss) on instrument specific credit risk 2,540             2,540
Net loss (128,177)           (128,177)  
Balance at Sep. 30, 2026 $ 356,972   $ 3   1,194,098   (839,477) 2,348
Balance, shares at Sep. 30, 2026 325,883,880   325,883,880          
Balance at Jun. 30, 2026 $ 387,266   $ 3   1,186,843   (800,349) 769
Balance, shares at Jun. 30, 2026     325,302,280          
Stock-based compensation 6,082       6,082      
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs   $ (44)       $ (44)    
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs, shares       0        
Issuance of common stock upon exercise of stock options, net 930       930      
Issuance of common stock upon exercise of stock options, net ,shares     509,032          
Issuance of common stock under ESPP 287       287      
Issuance of common stock under ESPP, shares     72,568          
Gain (loss) on instrument specific credit risk 1,579             1,579
Net loss (39,128)           (39,128)  
Balance at Sep. 30, 2026 $ 356,972   $ 3   $ 1,194,098   $ (839,477) $ 2,348
Balance, shares at Sep. 30, 2026 325,883,880   325,883,880